deferoxamine has been researched along with quercetin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantore, M; Ciuffi, M; Da Settimo, F; Failli, P; La Motta, C; Lavecchia, A; Marini, AM; Mugnaini, L; Novellino, E; Salerno, S; Sartini, S; Simorini, F; Taliani, S | 1 |
| Christen, Y; Clostre, F; Costentin, J; Naudin, B; Ramassamy, C | 1 |
| Fujimoto, Y; Fujita, T; Matsuno, K; Nishida, H; Sakuma, S; Sumiya, T; Takai, S | 1 |
| Cillard, J; Cillard, P; Lescoat, G; Morel, I | 1 |
| Harris, DC; Rangan, GK; Tay, YC; Wang, Y | 1 |
| Chikahisa, L; Funai, M; Kanemaru, K; Nakata, M; Noguchi, S; Okada, Y; Oyama, Y; Yamazaki, Y | 1 |
| Aherne, SA; O'Brien, NM | 1 |
| Kahraman, A; Polat, C; Sabuncuoğlu, B; Tokyol, C; Yìlmaz, S | 1 |
| Hao, L; Lehmann, A; Liu, L; Neuhaus, P; Nussler, A; Nussler, N; Song, F; Yao, P; Zhao, J | 1 |
| Chung, KT; Makena, PS; Pierce, SC; Sinclair, SE | 1 |
| Claro, LM; Comar, SR; do Nascimento, AJ; Krukoski, DW; Leonart, MS | 1 |
| Naftalin, RJ; Sharp, PA; Vlachodimitropoulou, E | 1 |
| Haleagrahara, N; Ponnusamy, K; Siew, CJ | 1 |
| Chen, M; Du, M; Li, Y; Liu, L; Sun, J; Tang, Y; Xiong, T; Xu, Y; Yao, P; Yu, X | 1 |
| Chen, M; Dong, Z; Gao, C; Guo, X; Liu, J; Liu, P; Tang, Y; Yao, P; Zeng, H; Zhang, J; Zhou, F; Zhu, X | 1 |
15 other study(ies) available for deferoxamine and quercetin
| Article | Year |
|---|---|
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.
Topics: Aldehyde Reductase; Animals; Antioxidants; Binding Sites; Catechols; Humans; Kidney; Lens, Crystalline; Models, Molecular; Pyridines; Pyrimidines; Rats; Structure-Activity Relationship; Tissue Extracts | 2007 |
Prevention by Ginkgo biloba extract (EGb 761) and trolox C of the decrease in synaptosomal dopamine or serotonin uptake following incubation.
Topics: Animals; Ascorbic Acid; Chromans; Corpus Striatum; Deferoxamine; Dopamine; Drug Interactions; Ginkgo biloba; In Vitro Techniques; Male; Mice; Plant Extracts; Quercetin; Serotonin; Synaptosomes; Tritium | 1992 |
Effect of tert-butyl hydroperoxide on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in rabbit platelets.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Arachidonic Acid; Blood Platelets; Deferoxamine; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Ferrous Compounds; Hydroxyeicosatetraenoic Acids; Indomethacin; Leukotrienes; Lipoxygenase; Male; Oxidants; Peroxides; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Quercetin; Rabbits; tert-Butylhydroperoxide; Thromboxane B2 | 1992 |
Role of flavonoids and iron chelation in antioxidant action.
Topics: Animals; Antioxidants; Catechin; Cells, Cultured; Chromatography, High Pressure Liquid; Culture Techniques; Deferoxamine; Flavonoids; Iron; Iron Chelating Agents; Lipid Peroxidation; Liver; Malondialdehyde; Quercetin; Rats; Rats, Sprague-Dawley | 1994 |
Inhibition of NFkappaB activation with antioxidants is correlated with reduced cytokine transcription in PTC.
Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Cell Survival; Cytokines; Deferoxamine; Hydrogen Peroxide; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Lipopolysaccharides; Male; NF-kappa B; Pyrrolidines; Quercetin; Rats; Rats, Wistar; Thiocarbamates; Transcription, Genetic | 1999 |
Exposure of rat thymocytes to hydrogen peroxide increases annexin V binding to membranes: inhibitory actions of deferoxamine and quercetin.
Topics: Animals; Annexin A5; Calcium; Cell Membrane; Cell Survival; Chelating Agents; Deferoxamine; Dose-Response Relationship, Drug; Ethidium; Fluorescein-5-isothiocyanate; Fluorescence; Hydrogen Peroxide; Oxidants; Protein Binding; Quercetin; Rats; Rats, Wistar; Thymus Gland | 1999 |
Mechanism of protection by the flavonoids, quercetin and rutin, against tert-butylhydroperoxide- and menadione-induced DNA single strand breaks in Caco-2 cells.
Topics: Butylated Hydroxytoluene; Caco-2 Cells; Cell Survival; Deferoxamine; DNA Damage; Free Radical Scavengers; Humans; Iron; Iron Chelating Agents; Phenanthrolines; Quercetin; Rutin; tert-Butylhydroperoxide; Vitamin K | 2000 |
The effects of desferrioxamine and quercetin on hepatic ischemia-reperfusion induced renal disturbance.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Deferoxamine; Glutathione; Kidney; Liver; Male; Malondialdehyde; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Reperfusion Injury; Time | 2006 |
The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage.
Topics: Allyl Compounds; Bilirubin; Carbon Monoxide; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Deferoxamine; Disulfides; Enzyme Inhibitors; Ethanol; Ferrous Compounds; Glutathione; Heme Oxygenase-1; Hemoglobins; Hepatocytes; Humans; Iron; L-Lactate Dehydrogenase; Liver Diseases, Alcoholic; Malondialdehyde; Organometallic Compounds; Protoporphyrins; Quercetin; Transaminases | 2009 |
Comparative mutagenic effects of structurally similar flavonoids quercetin and taxifolin on tester strains Salmonella typhimurium TA102 and Escherichia coli WP-2 uvrA.
Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Deferoxamine; Edetic Acid; Escherichia coli; Iron; Iron Chelating Agents; Liver Extracts; Microbial Sensitivity Tests; Mutagenesis; Mutagenicity Tests; Mutation; NADP; Quercetin; Rats; Salmonella typhimurium; Superoxide Dismutase | 2009 |
Effect of vitamin C, deferoxamine, quercetin and rutin against tert-butyl hydroperoxide oxidative damage in human erythrocytes.
Topics: Adult; Antioxidants; Ascorbic Acid; Deferoxamine; Erythrocytes; Female; Glucosephosphate Dehydrogenase; Glutathione; Heinz Bodies; Humans; Male; Methemoglobin; Middle Aged; Oxidative Stress; Quercetin; Rutin; tert-Butylhydroperoxide; Young Adult | 2009 |
Quercetin-iron chelates are transported via glucose transporters.
Topics: Animals; Cytochalasin B; Deferiprone; Deferoxamine; Dogs; Glucose Transport Proteins, Facilitative; Iron Chelating Agents; Pyridones; Quercetin; Signal Transduction; Spectrometry, Fluorescence | 2011 |
Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats.
Topics: Animals; Behavior, Animal; Corpus Striatum; Deferoxamine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease; Protein Carbonylation; Quercetin; Rats; Rats, Sprague-Dawley; Reaction Time; Superoxide Dismutase | 2013 |
Iron-Mediated Lysosomal Membrane Permeabilization in Ethanol-Induced Hepatic Oxidative Damage and Apoptosis: Protective Effects of Quercetin.
Topics: Animals; Apoptosis; Body Weight; Deferoxamine; Dietary Supplements; Ethanol; Feeding Behavior; Hepatocytes; Iron; Liver; Lysosomes; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Oxidation-Reduction; Oxidative Stress; Permeability; Protective Agents; Quercetin; Reactive Oxygen Species | 2016 |
Quercetin Attenuates Ethanol-Induced Iron Uptake and Myocardial Injury by Regulating the Angiotensin II-L-Type Calcium Channel.
Topics: Angiotensin II; Animals; Body Weight; Calcium Channels, L-Type; Deferoxamine; Ethanol; Heart; Iron; Male; Mice; Mice, Inbred C57BL; Myocardium; Quercetin | 2018 |